Skúšobnú verziu novej webovej stránky nájdete na beta.sukl.sk. Všetky aktuality, informácie a kompletný obsah sú zatiaľ prioritne dostupné na pôvodnej verzii webu.
en

PRODUCT DETAIL

Denosumab Intas 60 mg injekčný roztok v naplnenej injekčnej striekačke

Code 2212F
MA number EU/1/25/1993/001
Product Form: sol inj 1x1 ml/60 mg (striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Intas Third Party Sales 2005, S.L., Spain
Therapeutic Class: 87 - VARIA I
ATC:
M MUSCULO-SKELETAL SYSTEM
M05 DRUGS FOR TREATMENT OF BONE DISEASES
M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
M05BX Other drugs affecting bone structure and mineralization
M05BX04 Denosumab
Shelf life: 24
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(4) similar biological application
MA issued: 17.11.2025
Validity: 17.11.2030
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 12.12.2025
eu-flag.png sk-flag.png